In an analysis of over 10,000 IVF cycles, tailoring the HCG trigger dose to each patient led to fewer cases of ovarian hyperstimulation syndrome (OHSS) — a painful over-response to fertility treatment.
Directional — OHSS incidence lower with individualized dosing; exact rates not shown.













